RE: Harrods price paid for a Poundland share31 Mar 2021 13:52
Busymum, as I said yesterday this is a 1 off. It is for compassionate use as the patient and their doctor will have heard about Foralumab and requested to be allowed to use it having signed a disclaimer accepting the risks of taking an unapproved, investigational drug.
It could even be for a patient who needs the drug and applied for the trial but is not eligible for one reason or another.
It is not a substitute for the main P2 trial in MS. Nor will it provide any kind of indicator that is likely to influence any FDA decisions provided that it does not lead to a serious adverse event.
We need to see it in isolation as a result of Tils allowing a drug going through trials to be made available as a treatment. I held shares in a US company who offer a treatment for eczema and they make clear that while the drug is going through trials it is not currently available for Compassionate use.